Modified HIV Drug Reverses Vision Loss and Paralysis in MS Model
A NIH-funded study found that a modified HIV drug can reverse vision loss and paralysis in a multiple sclerosis (MS) model. Experimental tests on mice showed nerve repair and functional recovery, suggesting potential for treating MS symptoms. However, human trials are still needed to confirm these findings and assess safety and efficacy in patients.
Google News·15h ago



